You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 12, June 23, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Quality of Care, Other
 •Alert me on articles by topic

Oversight of Quality Improvement

Focusing on Benefits and Risks

Bernard Lo, MD; Michelle Groman, AB

Arch Intern Med. 2003;163:1481-1486.

Quality improvement (QI) may substantially improve patient outcomes while posing little risk to subjects. However, the term quality improvement is used to refer to a broad range of projects, which vary widely in the potential benefits and risks to participants. Some projects raise ethical concerns. An explicit protocol for the ethical review of QI would benefit both patients and leaders of QI projects. If a project is considered research rather than QI, review by an institutional review board and informed consent from subjects may be required. In contrast, QI projects may require little oversight beyond what is already in place for clinical care. However, a monolithic approach to oversight of QI is inappropriate in light of the variation in benefits and risks of QI projects and their overlap with research. The key ethical issue is not the classification of a project as QI or research, but the balance of anticipated benefits and harms in the project. We propose a protocol for independent review of QI projects and patient consent that will protect subjects from serious harm while encouraging QI projects that will substantially benefit participants and pose only minimal risk.


From the Program in Medical Ethics and the Division of General Internal Medicine, University of California, San Francisco. The authors have no relevant financial interest in this article.


RELATED LETTERS

Quality Improvement Projects: Inaction Presents the Greatest Risk
Charles Stimler
Arch Intern Med. 2003;163(21):2648-2649.
EXTRACT | FULL TEXT  

Quality Improvement Projects: Inaction Presents the Greatest Risk—Reply
Bernard Lo
Arch Intern Med. 2003;163(21):2649.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality Improvement and Ethical Oversight
Grady
ANN INTERN MED 2007;146:680-681.
FULL TEXT  

Research governance: where did it come from, what does it mean?
Shaw et al.
JRSM 2005;98:496-502.
ABSTRACT | FULL TEXT  

Institutional review board approval of projects presented as posters at an ASHP Midyear Clinical Meeting
Gonzalez et al.
Am J Health Syst Pharm 2005;62:1890-1893.
FULL TEXT  

Potential Impact of the HIPAA Privacy Rule on Data Collection in a Registry of Patients With Acute Coronary Syndrome
Armstrong et al.
Arch Intern Med 2005;165:1125-1129.
ABSTRACT | FULL TEXT  

Human Subjects Issues and IRB Review in Practice-Based Research
Wolf et al.
Ann Fam Med 2005;3:S30-S37.
ABSTRACT | FULL TEXT  

Why we need ethical oversight of quality improvement projects
Perneger
Int J Qual Health Care 2004;16:343-344.
FULL TEXT  

Quality Improvement Projects: Inaction Presents the Greatest Risk
Stimler
Arch Intern Med 2003;163:2648-2649.
FULL TEXT  

Risk of Unexplained Acute Liver Failure in Diabetes Mellitus
Graham
Arch Intern Med 2003;163:2649-2650.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.